« All Events

2026 WEBINAR | Quality as Strategy: How Three Health Systems Are Using Clinical AI to Make Proactive Care the Standard

September 30, 2026, 1:00 pm - 2:00 pm CDT

Login below to register and view any available materials for this event.
You must have a profile to login. CREATE PROFILE.

Jacob Strand, MD, Chair of Palliative Care, Mayo Clinic; Gregg Nicandri, MD, Chief Digital and Innovation Officer, University of Rochester Medicine; Rohit Chandra, PhD, Executive Vice President and Chief Digital Officer, Cleveland Clinic; and Suchi Saria, PhD, CEO & Founder of Bayesian Health, John C. Malone Endowed Chair and Director of AI & Health Lab, Johns Hopkins University. For health system leaders, clinical AI has moved from an innovation question to a strategy question. The systems that treat it that way, with clear criteria for what to invest in and hard expectations for what it must return, are beginning to separate from those that don’t.

This session brings together executives from Cleveland Clinic, University of Rochester Medicine, and Mayo Clinic to discuss how they are thinking strategically about AI investments. Each has made a deliberate bet on earlier, proactive care, powered by Bayesian Health’s real-time clinical intelligence platform that continuously monitors patients and surfaces rising risk hours before it would otherwise be recognized. It is a strategy they believe can move patient outcomes and financial metrics alike. They will speak candidly about how they evaluated the investment, what separates technology that delivers from technology that adds noise, and what results leaders should demand before committing at scale.

The conversation will also address the harder organizational question. Results depend on adoption, and adoption depends on trust. These leaders will share what it took to move their clinicians from skepticism to reliance, and how they built the governance and accountability that made proactive care the standard rather than the exception.

Attendees will leave with:

  • A framework for evaluating clinical AI investments, including the questions to ask and the evidence to require
  • An understanding of what needle-moving results look like across outcomes, operations, and margin
  • Lessons on building clinician trust and organizational momentum behind proactive care

Details